Genetic screening for human leukocyte antigen alleles prior to carbamazepine treatment

Marson, 2007, The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial, Lancet, 369, 1000, 10.1016/S0140-6736(07)60460-7 Wiffen, 2011, Carbamazepine for acute and chronic pain in adults, Cochrane Database Syst Rev, CD005451 Roujeau, 1994, Severe adverse cutaneous reactions to drugs, N Engl J Med, 331, 1272, 10.1056/NEJM199411103311906 Chung, 2004, Medical genetics: a marker for Stevens–Johnson syndrome, Nature, 428, 486, 10.1038/428486a Tangamornsuksan, 2013, Relationship between the HLA-B∗1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis, JAMA Dermatol, 149, 1025, 10.1001/jamadermatol.2013.4114 Mehta, 2009, Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians, Indian J Dermatol Venereol Leprol, 75, 579, 10.4103/0378-6323.57718 Alfirevic, 2006, HLA-B locus in Caucasian patients with carbamazepine hypersensitivity, Pharmacogenomics, 7, 813, 10.2217/14622416.7.6.813 Niihara, 2012, HLA-A31 strongly associates with carbamazepine-induced adverse drug reactions but not with carbamazepine-induced lymphocyte proliferation in a Japanese population, J Dermatol, 39, 594, 10.1111/j.1346-8138.2011.01457.x US Food and Drug Administration. Information for healthcare professionals: dangerous or even fatal skin reactions—carbamazepine (marketed as Carbatrol, Equetro, Tegretol, and generics). Available at: <http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm124718.htm>; 2007. Epilepsy Society of Australia 2009. ESA Position Statement: HLA testing for SJS. [Internet]. <http://www.epilepsy-society.org.au/resources/positions-and-guidelines-HLA-testing-for-sjs.asp> [accessed 20th January 2015]. Douglass Hanly Moir Pathology 2013. Overview of Pharmacogenomics testing [online]. <http://www.dhm.com.au/media/21900626/pharmacogenomics_brochure_2013_web.pdf> [accessed 26th April 2015]. Chen, 2011, Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan, N Engl J Med, 364, 1126, 10.1056/NEJMoa1009717